Abstract
Asthma is a highly regulated and complex disease process involving interactions between lung immunology, neural control, and inflammation that result in reversible early and/or late phase airflow obstruction, airway hyperreactivity, cellular infiltration, and histopathologic changes (e.g. mucus and bronchial smooth muscle cell hypertrophy). Much of our current understanding of this disease process, albeit incomplete, has been obtained through preclinical studies using in vivo models developed in a variety of species to target cellular, biochemical, and molecular mechanisms. Some of the more commonly used species that will be discussed in this review include mouse, guinea pig, rat, rabbit, sheep, dog, and primate. Excluded from this list due to practical considerations is the horse which commonly exhibits an allergic response (“heaves”) to hay mold spores [1]. Due to limitations of space, we have concentrated on the most recent applications, newer technologies, and drug therapies in these animal models whenever possible. Remember that no single animal model precisely mimics the human condition; however, each model helps advance the understanding of this complex disease process and establishes new, cost-effective therapeutic approaches.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gray PR, Derksen FJ, Broadstone RV, Robinson NE, Johnson HG, Olson NC (1992) Increased pulmonary production of immunoreactive 15-hydroxyeicosatetraenoic acid in an animal model of asthma. Am Rev Respir Dis 145: 1092–1097
Garlisi CG, Falcone A, Hey JA, Paster TM, Fernandez X, Rizzo CA, Minnicozzi M, Jones H, Billah MM, Egan RW, Umland SP (1997) Airway eosinophils, T cells, Th2-type cytokine mRNA and hyperreactivity in response to aerosol challenge of allergic mice with previously established pulmonary inflammation. Am J Respir Cell Mol Biol 17: 642–651
Hessel EM, Van Oosterhout AJM, Hofstra CL, DeBie JJ, Garssen J, Van Loveren H, Verheyen AKCP, Saveloul HFJ, Nijkamp FP (1995) Bronchoconstriction and airway hyper-responsiveness after ovalbumin inhalation in sensitized mice. Eur J Pharmacol 293: 401–412
Eum S-Y, Hailé S, Lefort J, Huerre M, Vargaftig BB (1995) Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin-5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci 92: 12290–12294
Hamelmann E, Oshiba A, Loader J, Larsen GL, Gleich G, Lee J, Gelfand EW (1997) Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med 155: 819–825
Levitt RC, Mitzner W (1989) Autosomal recessive inhertiance of airway hyperreactivity to 5-hydroxytryptamine. J Appl Physiol 67: 1125–1132
Levitt RC, Mitzner W, Kleeberger SR (1990) A genetic approach to the study of lung physiology: understanding biological variability in airway responsiveness. Am J Physiol 258: L157 - L164
Kung TT, Jones H, Adams III GK, Umland SP, Kreutner W, Egan RW, Chapman RW, Watnick AS (1994) Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Immunol 105: 83–90
Garlisi CG, Falcone A, Billah MM, Egan RW, Umland SP (1996) T cells are the predominant source of interleukin-5 but not interleukin-4 mRNA expression in the lungs of antigen-challenged allergic mice. Am J Respir Cell Mol Biol 15: 420–428
Kaminuma O, Mori A, Ogawa K, Nakata A, Kikkawa H, Naito K, Suko M, Okudaira H (1997) Successful transfer of late phase eosinophil infiltration in the lung by infusion of helper T cell clones. Am J Respir Cell Mol Biol 16: 448–454
Hogan SP, Koskinen A, Foster PS (1997) Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol 75: 284–288
Blyth DI, Pedrick MS, Savage TJ, Hessel EM, Fattah D (1996) Lung inflammation and epithelial changes in a murine model of atopic asthma. Am J Respir Cell Mol Biol 14: 425–438
Ohkawara Y, Lei XF, Stampfli MR, Marshall JS, Xing Z, Jordana M (1997) Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol 16: 510–520
Kung TT, Stelts D, Zurcher JA, Jones H, Umland SP, Kreutner W, Egan RW, Chapman RW (1995) Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol 12: 404–409
Martin TR, Takeishi T, Katz HR, Austen KF, Drazen JM, Galli SJ (1993) Mast cell activation enhances airway responsiveness to methacholine in the mouse. J Clin Invest 91: 1176–1182
Brusselle GG, Kips JC, Tavernier JM, Van der Heyden JG, Cavelier CA, Pauwels RA, Bluethmann H (1994) Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 24: 73–83
Corrigan CJ, Kay AB (1992) T cells and eosinophils in the pathogenesis of asthma. Immunol Today 13: 501–507
Mehlhop PD, Van de Rijnn M, Goldberg AB, Brewer JP, Kurup VP, Martin TR, Oettgen HC (1997) Allergen-induced hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci 94: 1344–1349
Korsgren M, Erjefält JS, Korsgren O, Sundler F, Persson CGA (1997) Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 185: 885–892
Van Oosterhout AJ, Hofstra CL, Shields R, Chan B, van Ark I, Jardieu PM, Nijkamp FP (1997) Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma. Am J Respir Cell Mol Biol 17: 386–392
Mosmann TR, Cherwinski H, Bond MW, Giedin MA, Coffman RL (1986) Two types of murine helper T cell clone I: Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348–2357
Gonzalo J-A, Lloyd CM, Kremer L, Finger E, Martinez-A C, Siegelman MH, Cybulsky M, Gutierrez-Ramos J-C (1996) Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines and adhesion receptors. J Clin Invest 98: 2332–2345
Chu HW, Wang JM, Boutet M, Boulet LP, Laviolette M (1996) Immunohistochemical detection of GM-CSF, IL-4 and IL-5 in a murine model of allergic bronchopulmonary aspergillosis. Clin Exp Allergy 26: 461–468
Bell SJD, Metzger WJ, Welch CA, Gilmour MI (1996) A role for Th2 T memory cells in early airway obstruction. Cell Immunol 170: 185–194
Elsas MICG, Joseph D, Elsas PX, Vargaftig BB (1997) Rapid increase in bone-marrow eosinophil production and response to eosinopoietic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol 17: 404–413
Karol MH (1994) Animal models of occupational asthma. Eur Respir J 7: 555–568
Martin TR, Gerard NP, Galli SJ, Drazen JM (1988) Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol 64: 2318–2323
Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW (1997) Non invasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156: 766–775
Stelts D, Falcone A, Egan RW, Falcone A, Garlisi CG, Gleich GJ, Kreutner W, Kung TT, Nahrebne DK, Chapman RW, Minnicozzi M (1998) Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. Am J Respir Cell Mol Biol 18: 463–470
Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM (1996) Interleukin 4, but not interleukin 5 or eosinophils is required in a murine model of acute airway hyperreactivity. J Exp Med 183: 109–117
Zhou CY, Crocker IC, Koenig G, Romero FA, Townley RG (1997) Anti-interleukin-4 inhibits immunoglobulin E production in a murine model of atopic asthma. J Asthma 34: 195–201
Kung TT, Stelts, DM, Zurcher JA, Adams III GL, Egan RW, Kreutner W, Watnick AS, Jones H, Chapman RW (1995) Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-S antibody. Am J Respir Cell Mol Biol 13: 360–365
Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG (1996) Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183: 195–201
Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, Brenneise IE, Horton MA, Haczku A, Gelfand EW et al (1997) Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 185: 2143–2156
O’Donnell M, Garippa J, Rinaldi N, Selig WM, Tocker JE, Tannu SA, Wasserman MA, Welton A, Bolin DR (1994) Ro 25–1553: A novel long-acting vasoactive intestinal peptide agonist. J Pharmacol Exp Ther 270: 1289–1294
Itoh K, Takahashi E, Mukaiyama O, Satoh Y, Yamaguchi T (1996) Relationship between airway eosinophilia and airway hyperresponsiveness in a late asthmatic model of guinea pigs. Int Arch Allergy Immunol 107: 86–94
Underwood S, Foster M, Raeburn D, Bottoms S, Karlsson J-A (1995) Time-course of antigen-induced airway inflammation in the guinea pig and its relationship to airway hyperresponsiveness. Eur Respir J 8: 2104–2113
Yamada N, Kadowaki S, Umezu K (1992) Development of an animal model of late asthmatic responses in guinea pigs and effects of anti-asthmatic drugs. Prostaglandins 43: 507–521
Matsumoto T, Ashida Y, Tsukuda R (1994) Pharmacological modulation of immediate and late airway response and leukocyte infiltration in the guinea pig. J Pharmacol Exp Ther 269: 1236–1244
Savoie C, Plant M, Zwikker M, van Staden CJ, Boulet L, Chan CC, Rodgers IW, Pon DJ (1995) Effect of dexamethasone on antigen-induced high molecular weight glycoconjugate secretion in allergic guinea pigs. Am J Respir Cell Biol 13: 133–143
Hsiue TR, Lei HY, Hsieh AL, Wang TY, Chang HY, Chen CR (1997) Mite-induced allergic airway inflammation in guinea pigs. Int Arch Allergy Immunol 112: 295–302
Riedel F, Krause A, Slenczka W, Rieger CHL (1996) Parainfluenza-3-virus infection enhances allergic sensitization in the guinea pig. Clin Exp Allergy 26: 603–609
Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P (1995) Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med 181: 1121–1216
Banner KH, Paul W, Page CP (1996) Ovalbumin challenge following immunization elicits recruitment of eosinophils but not bronchial hyperresponsiveness in guinea pigs: Time course and relationship to eosinophil activation status. Pulmonary Pharmacol 9: 179–187
Chapman ID, Morley J (1996) Eosinophil accumulation and airway hyperreactivity. Eur Respir J 9: 1331–1333
Underwood DC, Osborn RR, Hand JM (1992) Lack of late-phase airway responses in conscious guinea pigs after a variety of antigen challenges. Agents Actions 37: 191–194
Heuer HO, Wenz B, Jennewein HM, Urich K (1996) Characterization of a novel airway late phase model in the sensitized guinea pig which uses silica and Bordetella pertussis as adjuvant for sensitization. Eur J Pharmacol 317: 361–369
Santing RE, Olymulder CG, Zaagsma J, Meurs H, (1994) Relationship between allergen-induced early-and late-phase obstructions, bronchial hyperreactivity and inflammation in conscious, unrestrained guinea pigs. J Allergy Clin Immunol 93: 1021–1030
Griffiths-Johnson D, Karol M (1991) Validation of a noninvasive technique to assess development of airway hyperreactivity in an animal model of immunological pulmonary hypersensitivity. Toxicol 65: 283–294
Raeburn D, Underwood SL, Lewis SA, Woodman VR, Battram CH, Tomkinson A, Sharma S, Jordan R, Souness JE, Webber SE et al (1994) Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br J Pharmacol 113: 1423–1431
Santing RE, Olymulder CG, Van der Molen K, Meurs H, Zaagsma J (1995) Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs. Eur J Pharmacol 275: 75–82
Banner KH, Moriggi E, Da Ros B, Schioppacassi G, Semeraro C, Page CP (1996) The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation. Br J Pharmacol 119: 1255–1261
Hughes B, Howat D, Lisle H, Holbrook M, James T, Gozzard N, Blease K, Hughes P, Kingaby R, Warrellow G et al (1996) The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP 840, a novel stero-selective inhibitor of phosphodiesterase type 4. Br J Pharmacol 118: 1183–1191
Turner CR, Cohan VL, Cheng JB, Showell HJ, Pazoles CJ, Watson JW (1996) The in vivo pharmacology of CP-80,633, a selective inhibitor of phosphodiesterase 4. J Pharmacol Exp Ther 278: 1349–1355
Underwood DC, Matthews JK, Osborn RR, Bochnowicz S, Torphy TJ (1997) The influence of endogenous catecholamines on the inhibitory effects of rolipram against early-and late-phase response to antigen in the guinea pig. J Pharmacol Exp Ther 280: 210–219
Danahay H, Broadley KJ (1997) Effects of inhibitors of phosphodiesterase on antigeninduced bronchial hyperreactivity in conscious sensitized guinea pigs and airway leukocyte-infiltration. Br J Pharmacol 120: 289–297
Mauser PJ, Pitman A, Witt A, Fernandez X, Zurcher J, Kung T, Jones H, Watnick AS, Egan RW, Kreutner W, Adams GK (1993) Inhibitory effect of the TRFK-5 anti IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 148: 1623–1627
Akutsu I, Kojima T, Kariyone A, Fukuda T, Makino S, Takatsu K (1995) Antibody against interleukin-5.prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airways. Immunol Lett 45: 109–116
Humbles AA, Conroy DM, Marleau S, Rankin SM, Plaframan RT, Proudfoot AEI, Wells TNC, Li D, Jeffrey PK, Griffiths-Johnson DA et al (1997) Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways: Analysis in a guinea pig model in vivo. J Exp Med 186: 601–612
Watanabe A, Hayashi H (1990) Allergen-induced biphasic bronchoconstriction in rats. Int Arch Allergy Appl Immunol 93: 26–34
Kips JC, Cuvelier CA, Pauwels RA (1992) Effect of acute and chronic antigen inhalation on airway morphology and responsiveness in actively sensitized rats. Am Rev Respir Dis 145: 1306–130
Misawa M, Chiba Y (1993) Repeated antigenic challenge-induced airway hyperresponsiveness and airway inflammation in actively sensitized rats. Japan J Pharmacol 61: 41–50
Renzi PM, Al Assaad AS, Yang J, Yasruel Z, Hamid Q (1996) Cytokine expression in the presence or absence of late airway responses after antigen challenge of sensitized rats. Am J Respir Cell Mol Biol 15: 367–373
Schneider T, van Velzen D, Moqbel R, Issekutz AC (1997) Kinetics and quantification of eosinophil and neutrophil recruitment to allergic lung inflammation in a Brown Norway rat model. Am J Respir Cell Mol Biol 17: 702–712
Renzi PM, Olivenstein R, Martin JG (1993) Inflamamtory cell populations in the airways and parenchyma after antigen challenge in the rat. Am Rev Respir Dis 147: 967–974
Rabb HA, Olivenstein R, Issekutz TB, Renzi PM, Martin JG (1994) The role of the leukocyte adhesion molecules VLA-4, LFA-1, and Mac-1 in allergic airway responses in the rat. Am J Respir Crit Care Med 149: 1186–1191
Laberge S, Rabb H, Issekutz TB, Martin JG (1995) Role of VLA-4 and LFA-1 in allergen-induced airway hyperresponsiveness and lung inflammation in the rat. Am J Respir Crit Care Med 151: 822–829
Haczku A, Macary P, Haddad EB, Huang TJ, Kemeny DM, Moqbel R, Chung KF (1996) Expression of Th-2 cytokines interleukin-4 and -5 and of Th-1 cytokine interferon-g in ovalbumin-exposed sensitized Brown Norway rats. Immunol 88: 247–251
Howell RE, Jenkins LP, Fielding LE, Grimes D (1995) Inhibition of antigen-induced pulmonary eosinophilia and neutrophilia by selective inhibitors of phosphodiesterase types 3 or 4 in Brown Norway rats. Pulmonary Pharmacol 8: 83–89
Elwood W, Lotvall JO, Barnes PJ, Chung KF (1992) Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown Norway rats. Am Rev Respir Dis 145: 1289–1294
Nagase T, Fukuchi Y, Matsuse T, Sudo E, Matsui, Orimo H (1995) Antagonism of ICAM-1 attenuates airway and tissue responses to antigen in sensitized rats. Am J Respir Crit Care Med 151: 1244–1249
Richards IN, Kolbasa KP, Hatfield CA, Winterrowd GE, Vonderfecht SL, Fidler SF, Griffin RL, Brashler JR, Krzesicki RF, Sly LM et al (1996) Role of very late activation antigen-4 on the antigen-induced accumulation of eosinophils and lymphocytes in the lungs and airway lumen of sensitized Brown Norway rats. Am J Respir Cell Mol Biol 15: 172–183
Taylor BM, Kolbasa KP, Chin JE, Richards IM, Fleming WE, Griffin RL, Fidler SF, Sun FF (1997) Roles of adhesion molecules ICAM-1 and a4 integrin in antigen-induced changes in microvascular permeability associated with lung inflammation in Brown Norway rats. Am J Respir Cell Mol Biol 17: 757–766
Shampain MP, Behrens BL, Larsen GL, Henson PM (1982) An animal model of late pulmonary responses to Alternaria challenge. Am Rev Respir Dis 126: 493–498
Minshall EM, Riccio MM, Herd CM, Douglas GJ, Seeds EAM, McKenniff MG, Sasaki M, Spina D, Page CP (1993) A novel animal model for investigating persistent airway hyperresponsiveness. J Pharmacol Toxicol Methods 30: 177–188
Metzger WJ (1990) Late phase asthmatic responses in the allergic rabbit. In: W Dorsch (ed): Late phase allergic reactions. CRC, Boca Raton, FL, 347–362
Ali S, Mustafa SJ, Metzger WJ (1994) Adenosine receptor-mediated bronchoconstriction and bronchial hyperresponsiveness in an allergic rabbit model. Am J Physiol 266: L271 - L277
Behrens BL, Clark RAF, Presley DM, Graves JP, Feldsien DC, Larsen GL (1987) Comparison of the evolving histopathology of early and late cutaneous and asthmatic responses in rabbits after a single antigen challenge. Lab Invest 56: 101–113
Gozzard N, el-Hashim A, Herd CM, Blake SM, Holbrook M, Hughes B, Higgs GA, Page CP (1996) Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally immunised rabbits. Br J Pharmacol 118: 1201–1208
el-Hashim AZ, Jacques CA, Herd CM, Lee TM, Page CP (1997) The effect of R 15.7/HO, an anti-CD18 antibody on the late airway response and airway hyperresponsiveness in an allergic rabbit model. Br J Pharmacol 121: 671–678
Gozzard N, Herd CM, Blake SM, Holbrook M, Hughes B, Higgs GA, Page CP (1996) Effects of theophylline and rolipram on antigen-induced airway responses in neonatally immunized rabbits. Br J Pharmacol 117: 1405–1412
Minshall E, Spina D, Page CP (1996) Effects of neonatal immunization and repreated allergen exposure on airway responsiveness in the rabbit. J Appl Physiol 80: 2108–2119
Song B-Z, Donoff RB, Tsuji T, Todd R, Gallagher GT, Wong DTW (1993) Identification of rabbit eosinophils and heterophils in cutaneous healing wounds. Histochem J 25: 762–771
Larsen GL, Shampain MP, Marsh WR, Behrens BL (1984) An animal model of the late asthmatic response to antigen challenge. In: AB Kay (ed): Asthma — physiology, immunopharmacology and treatment. Academic Press, London, UK, 245–262
Nyce JW, Metzger WJ (1997) DNA antisense therapy for asthma in an animal model. Nature 385: 721–725
Ali S, Mustafa SJ, Metzger WJ (1994) Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: Evidence for an inducible adenosine Al receptor. J Pharmacol Exp Ther 268: 1328–1334
el-Hashim A, D’Agostino B, Matera MG, Page C (1996) Characterization of adeonsine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits. Br J Pharmacol 119: 1262–1268
Lobb RR, Repinsky B, Leone DR, Abraham WM (1996) The role of a4 integrins in lung pathophsyiology. Eur Respir J 22: 104s - 108s
Fujimoto K, Kubo K, Okada K, Kobayashi T, Sekiguchi M, Sakai A (1996) Effect of the 21-aminosteroid U-740067 on antigen-induced bronchoconstriction and bronchoalveolar eosinophilia in allergic sheep. Eur Respir J 9: 2044–2049
Abraham WM, Ahmed A, Cortes A, Sielczak M, Wantanabe A (1996) Effect of TYB2285 on antigen-induced airway responses in sheep. Pulmonary Pharmacol 9: 49–58
Mariassy AT, Abraham WM, Wanner A (1994) Effect of antigen on the glyconjugate profile of tracheal secretions and the epithelial glycocalyx in allergic sheep. J Allergy Clin Immunol 93: 585–593
Clark JM, Abraham WM, Fishman CE, Forteza R, Ahmed A, Corts A, Warne RL, Moore WR, Tanaka RD (1995) Tryptase inhibitors block allergen-induced airway and inflammatory responses. Am J Respir Crit Care Med 152: 2076–2083
Noguchi K, Ishikawa K, Yano M, Ahmed A, Cortes A, Abraham WM (1995) Endothelin-1 contributes to antigen-induced airway hyperresponsiveness. J Appl Physiol 79: 700–705
Jones TR, Labelle M, Belley M, Champion E, Charette L, Evans J, Ford-Hutchinson AW, Gauthier JY, Masson P et al (1995) Pharmacology of montelukast sodium (SingulairTM), a potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol 73: 191–201
de Weck AL, Mayer P, Stumper B, Schiessel B, Pickat L (1997) Dog allergy, a model for allergy genetics. Int Arch Allergy Immunol 113: 55–57
Collie DDS, DeBoer DJ, Muggenburg BA, Bice DE (1997) Evaluation of association of blood and bronchoalveolar eosinophil number and serum total immunoglobulin. Am J Vet Res 58: 34–39
Becker AB, Black C, Lilley MK, Bajawa K, Ford-Hutchinson AW, Simons FER, Tagari P (1995) Antiasthmatic effects of a leukotriene biosynthesis inhibitor (MK-0591) in allergic dogs. J Appl Physiol 78: 615–622
Itabashi S, Ohrui T, Sekizawa, Aikawa T, Nakazawa H, Sasaki H (1993) Late phase asthmatic resposnes cause peripheral airway hyperresponsiveness in dogs treated with metopirone. Int Arch Allergy Immunol 101: 215–220
Chung KF, Becker AB, Lazarus SC, Frick OL, Nadel JA, Gold WM (1985) Antigen-induced airway hyperresponsiveness and pulmonary inflammation in allergic dogs. J Appl Physiol 58: 1347–1353
Woolley MJ, Lane CG, Ellis R, Stevens WH, Woolley KL, O’Byrne PM (1995) Role of airway eosinophils in the development of allergen-induced airway hyperresponsiveness in dogs. Am J Respir Crit Care Med 152: 1508–1512
Baldwin F, Becker AB (1993) Bronchoalveolar eosinophilic cells in a canine model of asthma: Two distinct populations. Vet Pathol 30: 97–103
Emala C, Hirshman C (1996) Animal models of bronchial hyperreactivity. In: IP Hall (ed): Genetics of asthma and atopy. Monogr Allergy. Karger, Basel, 33: 35–52
Richards IM, Griffin RL, Oostveen JA, Elfring G, Conder GA (1988) Role of cyclooxygenase products of arachidonic acid metabolism in Ascaris antigen-induced bronchoconstriction in sensitized dogs. J Pharmacol Exp Ther 245: 735–741
Freed AN, Omori C, Hubbard WC, Adkinson NF (1994) Dry air-and hypertonic aerosol-induced bronchoconstriction and cellular responses in canine lung periphery. Eur Respir J 7: 1308–1316
Tabachnik E, Schuster A, Gold WM, Nadel JA (1992) Role of neutrophil elastase in allergen-induced lysozyme secretion in the dog trachea. J Appl Physiol 73: 695–700
Kaneko T, Massion PR, Hara M, Nadel JA (1996) Ragweed antigen causes interleukin- 8 production in sensitized dog trachea. Am J Respir Crit Care Med 153: 136–140
Woolley MJ, Denburg JA, Ellis R, Dahlback M, O’Byrne PM (1994) Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. Am J Respir Cell Mol Biol 11: 600–606
Inman MD, Denburg JA, Ellis R, Dahlback M, O’Byrne PM (1997) The effect of treatment with budesonide or PGE2 in vitro on allergen-induced increases in canine bone marrow progenitors. Am J Respir Cell Mol Biol 17: 634–641
Denburg JA, Inman MD, Wood L, Ellis R, Sehmi R, Dahlback M, O’Byrne PM (1997) Bone marrow progenitors in allergic airways disease: Studies in canine and human models. Int Arch Allergy Immunol 113: 181–183
Inman MD, Denburg JA, Ellis R, Dahlback M, O’Byrne PM (1996) Allergen-induced increases in bone marrow progenitors in airway hyperresponsiveness in dogs: Regulation by a serum hemopoietic factor. Am J Respir Cell Mol Biol 15: 305–311
Patterson R, Kelly JF (1974). Animal models of the asthmatic state. Ann Rev Med 25: 53–68
Johnson HG, Stout BK (1989) Ascaris suum ova-induced bronchoconstriction, eosinophilia, and IgE antibody responses in experimentally infected primates did not lead to histamine hyperreactivity. Am Rev Respir Dis 139: 710–714
Gundel RH, Gerritsen ME, Gleich GJ, Wegner CD (1990) Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. J Appl Physiol 68: 779–786
Gundel RH, Wegner CD, Letts LG (1992) Antigen-induced acute and late-phase responses in primates. Am Rev Respir Dis 146: 369–373
Mauser PJ, Pitman AM, Fernandez X, Foran SK, Adams III GK, Kreutner W, Egan RW, Chapman RW (1995) Effect of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 152: 467–472
Turner CR, Anderson CJ, Smith WK, Watson JW (1996) Characterization of a primate model of asthma using anti-allergy/anti-asthma agents. Inflamm Res 45: 239–245
McFarlane CS, Piechuta H, Hall RA, Ford-Hutchinson AW (1984) Effects of a contractile prostaglandin antagonist (L-640,035) upon allergen-induced bronchoconstriction in hyperreactive rats and conscious squirrel monkeys. Prostaglandins 28: 173–182
Hamel R, McFarlane CS, Ford-Hutchinson AW (1986) Late pulmonary responses induced by Ascaris allergen in conscious squirrel monkeys. J Appl Physiol 61: 2081–2087
Patterson R, Harris KE (1992) IgE-mediated rhesus monkey asthma: natural history and individual animal variation. Int Arch Allergy Immunol 97: 154–159
Ferreira FD, Mayer P, Sperr WH, Valent P, Seiberler S, Ebner C, Liehl E,Scheiner O, Kraft D, Valenta R (1996) Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet IT 1 and Bet IT 2. J Allergy Clin Immunol 97: 95–103
Fox JA, Hotaling TE, Struble C, Ruppel J, Bates DJ, Schoenhoff MB (1996) Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys. J Pharmacol Exp Ther 279: 1000–1008
Meng YG, Singh N, Wong WL (1996) Binding of cynomolgus monkey IgE to a humanized anti-human IgE antibody and human high affinity IgE receptor. Mol Immunol 33: 635–642
Osborn RR, Hay DWP, Wasserman MA, Torphy TJ (1992) SKandF 104353, a selective leukotriene receptor antagonist, inhibits leukotriene D4-and antigen-induced bronchoconstriction in cynomolgus monkeys. Pulmon Pharmacol 5: 153–157
Turner CR, Breslow R, Conklyn MJ, Andresen CJ, Patterson DK, Lopez-Anaya A, Owens B, Lee P, Watson JW, Showell HJ (1996) In vitro and in vivo effects on leukotriene B4 antagonism in a primate model of asthma. J Clin Invest 97: 381–387
Gundel RH, Torcellini CA, Clarke CC, DeSai S, Lazer ES, Wegner CD (1990) The effects of a 5-lipoxygenase inhibitor on antigen-induced mediator release, late phase bronchoconstriction and cellular infiltrates in primates. Adv Prostaglandin Thromb Leuk Res 21: 457–460
Allen DL, Herman DR, Williams GD, Spaethe SM, Dorato MA, Wolff RK (1995) Effect of an LTB4 aerosol exposure on pulmonary function, cell populations, and mediators in the lungs of rhesus monkeys. Inhalation Toxicol 7: 1141–1152
Gundel RH, Kikade P, Torcellini CA, Clark CC, Watrous J, Desai S, Homon CA, Farina PR, Wegner CD (1991) Antigen-induced mediator release in primates. Am Rev Respir Dis 144: 76–82
Turner CR, Smith WB, Andresen CJ, Swindell AC, Watson JW (1994) Leukotriene D4 receptor antagonism reduces airway hyperresponsiveness in monkeys. Pulm Pharmacol 7: 49–58
Patterson R, Harris KE, Krell RD (1988) Effect of a leukotriene D4 (LTD4) antagonist on LTD4 and Ascaris antigen-induced airway responses in rhesus monkeys. Int Arch Allergy Appl Immunol 86: 440–445
Turner CR, Andresen CJ, Smith WB, Watson JW (1994) Effect of rolipram on responses to acute and chronic antigen exposure in monkeys. Am J Respir Crit Care Med 149: 1153–1159
Katayama S, Sakuma Y, Abe S, Tsunoda H, Yamatsu I, Katayama K (1993) Inhibition of IgE-mediated leukotriene generation and bronchoconstriction in primates with a new 5-lipoxygenase inhibitor, E6080. Int Arch Allergy Immunol 100: 178–184
Johnson HG, Stout BK (1993) Late phase bronchoconstriction and eosinophilia as well as methacholine hyperresponsiveness in Ascaris-sensitive rhesus monkeys were reversed by oral administration of U-83836E. Int Arch Allergy Immunol 100: 362–366
Hogan MB, Harris KE, Protter AA, Patterson R (1996) A bradykinin antagonist inhibits both bradykinin and the allergen-induced airway response in primates. Proc Assoc Am Phys 109: 269–274
Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R (1990) Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247: 456–459
Gundel RH, Wegner CD, Torcellini CA, Clarke CC, Haynes N, Rothlein R, Smith CW, Letts LG (1991) Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys. J Clin Invest 88: 1407–1411
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
Selig, W.M., Chapman, R.W. (1999). Asthma. In: Morgan, D.W., Marshall, L.A. (eds) In Vivo Models of Inflammation. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7775-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7775-6_5
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-7777-0
Online ISBN: 978-3-0348-7775-6
eBook Packages: Springer Book Archive